A detailed history of Mgo One Seven LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mgo One Seven LLC holds 1,332 shares of CRL stock, worth $262,270. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,332
Previous 1,514 12.02%
Holding current value
$262,270
Previous $312,000 16.03%
% of portfolio
0.01%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$187.96 - $245.29 $34,208 - $44,642
-182 Reduced 12.02%
1,332 $262,000
Q2 2024

Aug 07, 2024

SELL
$206.39 - $268.73 $4,540 - $5,912
-22 Reduced 1.43%
1,514 $312,000
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $82,018 - $110,192
-403 Reduced 20.78%
1,536 $416,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $37,675 - $54,694
-229 Reduced 10.56%
1,939 $458,000
Q3 2023

Nov 03, 2023

SELL
$194.44 - $217.61 $9,138 - $10,227
-47 Reduced 2.12%
2,168 $424,000
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $14,329 - $16,399
78 Added 3.65%
2,215 $465,000
Q1 2023

May 08, 2023

SELL
$191.89 - $259.92 $1,918 - $2,599
-10 Reduced 0.47%
2,137 $431,000
Q4 2022

Jan 25, 2023

SELL
$197.11 - $250.07 $39,816 - $50,514
-202 Reduced 8.6%
2,147 $0
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $21,163 - $29,062
-116 Reduced 4.71%
2,349 $648,000
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $73,486 - $108,863
-360 Reduced 12.74%
2,465 $527,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $188,310 - $266,875
-737 Reduced 20.69%
2,825 $802,000
Q4 2021

Feb 09, 2022

BUY
$351.38 - $448.68 $41,814 - $53,392
119 Added 3.46%
3,562 $1.34 Million
Q3 2021

Nov 09, 2021

SELL
$372.64 - $458.3 $80,862 - $99,451
-217 Reduced 5.93%
3,443 $1.55 Million
Q2 2021

Jul 29, 2021

BUY
$294.17 - $371.65 $25,886 - $32,705
88 Added 2.46%
3,660 $1.35 Million
Q1 2021

Apr 29, 2021

SELL
$249.67 - $299.48 $7,240 - $8,684
-29 Reduced 0.81%
3,572 $1.04 Million
Q4 2020

Jan 22, 2021

SELL
$222.0 - $252.62 $39,516 - $44,966
-178 Reduced 4.71%
3,601 $900,000
Q3 2020

Oct 30, 2020

SELL
$175.56 - $226.45 $15,624 - $20,154
-89 Reduced 2.3%
3,779 $856,000
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $25,194 - $40,220
-212 Reduced 5.2%
3,868 $674,000
Q1 2020

Apr 17, 2020

SELL
$98.9 - $178.34 $21,164 - $38,164
-214 Reduced 4.98%
4,080 $514,000
Q4 2019

Jan 16, 2020

SELL
$126.05 - $152.76 $3,907 - $4,735
-31 Reduced 0.72%
4,294 $655,000
Q3 2019

Oct 10, 2019

BUY
$125.07 - $143.67 $16,259 - $18,677
130 Added 3.1%
4,325 $573,000
Q2 2019

Jul 16, 2019

SELL
$123.4 - $148.55 $50,100 - $60,311
-406 Reduced 8.82%
4,195 $595,000
Q1 2019

Apr 09, 2019

BUY
$104.82 - $146.73 $220,750 - $309,013
2,106 Added 84.41%
4,601 $668,000
Q4 2018

Jan 24, 2019

SELL
$105.09 - $137.23 $28,059 - $36,640
-267 Reduced 9.67%
2,495 $282,000
Q3 2018

Oct 09, 2018

SELL
$112.11 - $134.54 $18,049 - $21,660
-161 Reduced 5.51%
2,762 $371,000
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $12,961 - $15,206
-132 Reduced 4.32%
2,923 $312,000
Q4 2017

Feb 16, 2018

BUY
$100.43 - $118.09 $306,813 - $360,764
3,055
3,055 $334,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.